Literature DB >> 27038315

Major motor-functional determinants associated with poor self-reported health-related quality of life in myasthenia gravis patients.

David Cioncoloni1, Stefania Casali2, Federica Ginanneschi2, Marisa Carone2, Boni Veronica2, Alessandro Rossi2, Fabio Giannini2.   

Abstract

Myasthenia gravis (MG) is an autoimmune neuromuscular disorder in which disabling muscle weakness may affect health-related quality of life (HRQoL). The aim of this study was to investigate which common motor-functional deficits and corresponding severity are most determinant of poor HRQoL in these patients. In 41 patients, the dichotomized first item of the Italian Myasthenia Gravis Questionnaire (IMGQ), categorizing patients who report "good" and "poor" HRQoL, was chosen as dependent-outcome variable. All items composing the myasthenia gravis-specific scale (MG-ADL), i.e. talking, chewing, swallowing, breathing, impairment of ability to brush teeth or comb hair, impairment of ability to rise from chair, double vision, and eyelid droop were acquired as independent variables and dichotomized. Stepwise backward LR multivariable logistic regression analysis was performed. In addition, the main characteristics of patients were compared. MG-ADL items "chewing" ≥1, i.e. "fatigue chewing solid food", and "breathing" ≥2, i.e. "shortness of breath at rest" proved to be significant determinants. Higher dose of corticosteroid therapy was significantly (p = 0.027; r s  = -0.35), correlated with poor HRQoL. At diagnosis, a decremental response to repetitive nerve stimulation (RNS) from the abductor pollicis brevis was significantly more frequent in patients with poor HRQoL. In conclusion, impaired "chewing" and "breathing" functions indicate the need for careful planning of rehabilitation, re-education and patient management. Moreover, decremental response to RNS at diagnosis may identify patients at risk for poor HRQoL.

Entities:  

Keywords:  Activities of daily living; Myasthenia gravis; Outcome and process assessment; Prognosis; Quality of life; Rehabilitation

Mesh:

Year:  2016        PMID: 27038315     DOI: 10.1007/s10072-016-2556-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  36 in total

Review 1.  Course and prognosis of myasthenia gravis: a systematic review.

Authors:  Z-F Mao; X-A Mo; C Qin; Y-R Lai; T C Olde Hartman
Journal:  Eur J Neurol       Date:  2010-04-12       Impact factor: 6.089

2.  Myasthenia gravis: sleep quality, quality of life, and disease severity.

Authors:  Elena Hernández Martínez-Lapiscina; Elena Hernández Martínez De Lapiscina; María Elena Erro; María Elena Erro Aguirre; Teresa Ayuso; Teresa Ayuso Blanco; Ivonne Jericó; Ivonne Jericó Pascual
Journal:  Muscle Nerve       Date:  2012-08       Impact factor: 3.217

3.  Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.

Authors:  W Hoch; J McConville; S Helms; J Newsom-Davis; A Melms; A Vincent
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

4.  The effect of respiratory muscle endurance training in patients with myasthenia gravis.

Authors:  Beate Rassler; Guido Hallebach; Petra Kalischewski; Irene Baumann; Joachim Schauer; Christina M Spengler
Journal:  Neuromuscul Disord       Date:  2007-03-01       Impact factor: 4.296

5.  Standards of measurements in myasthenia gravis.

Authors:  Richard J Barohn
Journal:  Ann N Y Acad Sci       Date:  2003-09       Impact factor: 5.691

Review 6.  Measuring health-related quality of life.

Authors:  G H Guyatt; D H Feeny; D L Patrick
Journal:  Ann Intern Med       Date:  1993-04-15       Impact factor: 25.391

Review 7.  Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity.

Authors:  Matthew N Meriggioli; Donald B Sanders
Journal:  Lancet Neurol       Date:  2009-05       Impact factor: 44.182

8.  Maximal voluntary ventilation in myasthenia gravis.

Authors:  Ioannis Heliopoulos; Georgios Patlakas; Kostantinos Vadikolias; Nicolaos Artemis; Kleopas A Kleopa; Eustratios Maltezos; Haritomeni Piperidou
Journal:  Muscle Nerve       Date:  2003-06       Impact factor: 3.217

Review 9.  Diagnostic and clinical classification of autoimmune myasthenia gravis.

Authors:  Sonia Berrih-Aknin; Mélinée Frenkian-Cuvelier; Bruno Eymard
Journal:  J Autoimmun       Date:  2014-02-13       Impact factor: 7.094

Review 10.  Myasthenia gravis.

Authors:  Vern C Juel; Janice M Massey
Journal:  Orphanet J Rare Dis       Date:  2007-11-06       Impact factor: 4.123

View more
  4 in total

1.  Validity, reliability, and sensitivity to change of the myasthenia gravis activities of daily living profile in a sample of Italian myasthenic patients.

Authors:  Alberto Raggi; Carlo Antozzi; Fulvio Baggi; Matilde Leonardi; Lorenzo Maggi; Renato Mantegazza
Journal:  Neurol Sci       Date:  2017-08-05       Impact factor: 3.307

Review 2.  Quality of life in refractory generalized myasthenia gravis: A rapid review of the literature.

Authors:  Nathaly Garzón-Orjuela; Laura van der Werf; Laura Catalina Prieto-Pinto; Pieralessandro Lasalvia; Camilo Castañeda-Cardona; Diego Rosselli
Journal:  Intractable Rare Dis Res       Date:  2019-11

3.  Factors associated with quality of life of people with Myasthenia Gravis.

Authors:  Ansuk Jeong; Ju-Hong Min; Yu Kyoung Kang; Juhyeon Kim; Misong Choi; Jin Myoung Seok; Byung Joon Kim
Journal:  PLoS One       Date:  2018-11-08       Impact factor: 3.240

4.  The Lived Experience of Myasthenia Gravis: A Patient-Led Analysis.

Authors:  Nancy Law; Kelly Davio; Melissa Blunck; Dawn Lobban; Kenza Seddik
Journal:  Neurol Ther       Date:  2021-10-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.